Insider · CIK 0001295432
Peter J. Thornton
Files at AVDL (AVADEL PHARMACEUTICALS PLC). First filing Jan 14, 2025, latest Jan 14, 2025.
In brief
Peter J. Thornton files SEC Form 4 as director at AVDL (AVADEL PHARMACEUTICALS PLC). Since Jan 14, 2025, Peter J. Thornton has reported 1 open-market buy worth $80k and 0 open-market sells worth $0, the latest filed on Jan 14, 2025.
A track record needs three past buys with six months of prices behind them; Peter J. Thornton has 0, so none is measured yet.
The newest scored trade: bought $80k of AVDL on Jan 13, 2025, filed Jan 14, 2025, scored 42 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | AVADEL PHARMACEUTICALS PLC | $80k 10,000 shares | +11% | - |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Ordinary Shares | -115,060 | $21.00 | $2.4M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -33,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,000 | - | - | 0 | Feb 12, 2026 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Ordinary Shares | +11,000 | $0.00 | $0 | 115,055 | Jul 31, 2025 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Stock Option (Right to Buy)derivative | +11,000 | $0.00 | $0 | 11,000 | Jul 31, 2025 |
| Jan 13, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | POpen-market purchase Ordinary Shares | +10,000 | $8.05 | $80k | 104,055 | Jan 14, 2025 |
Questions about Peter J. Thornton
Answered from the filings on this page, as of the latest one.
Is Peter J. Thornton buying or selling?
Not in the last 12 months. Peter J. Thornton's latest open-market trade on SEC Form 4 was bought $80k of AVDL on Jan 13, 2025.
How did Peter J. Thornton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter J. Thornton has 0.
Where does Peter J. Thornton file Form 4?
Peter J. Thornton has filed Form 4 at AVDL (AVADEL PHARMACEUTICALS PLC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.